tiprankstipranks
Advertisement
Advertisement

DRMA Stock Latest News

Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
The FlyDermata Therapeutics appoints Kyra Peckaitis as VP, marketing
14d ago
DRMA
Dermata Therapeutics announces release of Tome Skincare
PremiumThe Fly
Dermata Therapeutics announces release of Tome Skincare
19d ago
DRMA
Dermata Therapeutics Announces Board Resignation and Size Reduction
PremiumCompany Announcements
Dermata Therapeutics Announces Board Resignation and Size Reduction
27d ago
8K
DRMA
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
PremiumCompany Announcements
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
2M ago
8K
DRMA
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
PremiumThe Fly
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
2M ago
DRMA
Dermata Therapeutics receives notice of grant of patent for acne treatment
PremiumThe FlyDermata Therapeutics receives notice of grant of patent for acne treatment
2M ago
DRMA
Dermata Therapeutics Raises Capital via December Private Placement
Premium
Company Announcements
Dermata Therapeutics Raises Capital via December Private Placement
3M ago
8K
DRMA
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
Premium
The Fly
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
3M ago
DRMA
Dermata Therapeutics to reveal brand name for OTC skincare business
PremiumThe Fly
Dermata Therapeutics to reveal brand name for OTC skincare business
4M ago
DRMA
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
PremiumRatings
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
4M ago
DRMA
Dermata Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Dermata Therapeutics files $100M mixed securities shelf
4M ago
DRMA
Dermata Therapeutics Ends License Agreement with Villani
PremiumCompany Announcements
Dermata Therapeutics Ends License Agreement with Villani
4M ago
8K
DRMA
Dermata Therapeutics Shifts Focus to OTC Skincare
PremiumCompany AnnouncementsDermata Therapeutics Shifts Focus to OTC Skincare
4M ago
8K
DRMA
Dermata Therapeutics Increases Stock Offering by $1.79M
Premium
Company Announcements
Dermata Therapeutics Increases Stock Offering by $1.79M
5M ago
8K
DRMA
Dermata says Australian Patent Office accepts Spongilla tech application
Premium
The Fly
Dermata says Australian Patent Office accepts Spongilla tech application
6M ago
DRMA
Dermata Therapeutics Presents Promising Phase 3 Trial Results
PremiumCompany Announcements
Dermata Therapeutics Presents Promising Phase 3 Trial Results
6M ago
8K
DRMA
Dermata Shifts Focus to Over-the-Counter Dermatology
PremiumCompany Announcements
Dermata Shifts Focus to Over-the-Counter Dermatology
6M ago
8K
DRMA
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
PremiumThe Fly
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
6M ago
DRMA
Dermata Therapeutics withdraws IND application for XYNGARI
PremiumThe Fly
Dermata Therapeutics withdraws IND application for XYNGARI
6M ago
DRMA
Dermata Therapeutics Regains Nasdaq Compliance by August 2025
PremiumCompany AnnouncementsDermata Therapeutics Regains Nasdaq Compliance by August 2025
7M ago
8K
DRMA
Dermata Therapeutics price target lowered to $10 from $30 at Maxim
Premium
The Fly
Dermata Therapeutics price target lowered to $10 from $30 at Maxim
7M ago
DRMA
Dermata Therapeutics Reports Positive Phase 3 Trial Results
Premium
Company Announcements
Dermata Therapeutics Reports Positive Phase 3 Trial Results
7M ago
8K
DRMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >